{
    "organizations": [],
    "uuid": "6d8ca3c33dafaf1a83162f9ccd736e71fd76e937",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-hybio-pharmaceutical-receives-pate/brief-hybio-pharmaceutical-receives-patent-license-idUSL4N1QH1YU",
    "ord_in_thread": 0,
    "title": "BRIEF-Hybio Pharmaceutical receives patent license",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 27(Reuters) - Hybio Pharmaceutical Co Ltd :\n* Says co received a patent license (No.ZL 2013 1 0676431.5), named synthetic method for eptifibatide\nSource text in Chinese: goo.gl/28tf22\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-02-27T11:18:00.000+02:00",
    "crawled": "2018-02-27T15:04:29.001+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "hybio",
        "pharmaceutical",
        "co",
        "ltd",
        "say",
        "co",
        "received",
        "patent",
        "license",
        "named",
        "synthetic",
        "method",
        "eptifibatide",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}